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Disease of the respiratory tract is a major problem for cattle and it continues to cause
serious economic losses for producers. Bovine respiratory disease (BRD) causes increased death
losses as well as medication costs, labor, and lost production. Many different infectious agents
may cause similar clinical signs. Multiple agents are often involved in the development of BRD.
DISEASE CONDITIONS (OR SYNDROMES)
The respiratory diseases of cattle can be divided into three main categories:
1. Upper respiratory tract infections
These infections cause inflammation of the nostrils, throat (pharynx) and windpipe
(trachea). The clinical signs are usually mild and involve coughing, nasal discharge, fever, and a
decreased appetite.
2. Diphtheria
This infection involves the larynx (voice box) and may occur alone or along with other
respiratory infections. There are often loud noises during breathing and the swelling may
severely restrict the air flow and result in death of the animal.
3. Pneumonia (lower respiratory tract infection)
An infection of the lungs is often due to an extension of infection from the upper
respiratory tract (#1) or a failure of the mechanisms which are designed to protect the lungs. It is
much more serious and causes more severe signs than does an upper respiratory infection.
Shipping fever is one form of lower respiratory tract disease and derives its name from the usual
occurrence of the disease shortly after shipment of the cattle.
CAUSES AND DEVELOPMENT OF DISEASE
The causes of BRD are multiple and complex, but the three factors of stress, viral
infection and bacterial infection are almost always involved in cases of severe disease. A wide
variety of different stressors and agents may be involved in the disease process.
Stress Factors Viral Agents Bacteria
Heat PI3 Pasteurella
Cold IBR Hemophilus
Dust BVD Other
Dampness BRSV
Injury Adenovirus
Fatigue Rhinovirus
Dehydration Herpesvirus IV  
Hunger Enterovirus
Anxiety MCF
Irritant gases Reovirus
Nutritional deficiencies
Surgery
Some of the viral agents produce only mild clinical signs by themselves but when
combined with other viral or bacterial agents and stress they may cause severe signs and death.
Many normal cattle carry one or more of the bacterial and viral agents in their upper respiratory
system with no ill effects. These often enter the lungs but are usually expelled or inactivated.
However, under stress the animal’s defense mechanisms may be overcome, and the infection
established, resulting in BRD. The mixing of cattle from different sources and wide environmental
temperature fluctuations have been identified as major factors in the initiation of disease outbreaks
in feedlots.
 
CLINICAL SIGNS
The most common signs of BRD are nasal and eye discharges, coughing, fever, decreased
appetite, varying degrees of breathing difficulty and noise, rapid breathing, depression, droopy
ears, open mouthed breathing and death. These vary greatly, depending on the stage and extent of
the disease process.
TREATMENT
In the past, there have been no drugs effective against viral agents in the treatment of
cattle for respiratory disease. Through current research, some products may become available for
use in the future. The antibiotics and sulfas have no effect on the viral agents but are often of
great aid against the bacterial invaders. 
Treatment of BRD will be effective and the death loss minimal if the following principles
are practiced: 1) early disease detection so those ill can be treated and separated to a sick pen; 2)
prompt initiation of an effective treatment program and continuation on a daily basis; 3) continued
treatment until 48 hours after signs have abated; 4) change to an alternate treatment if there is no
or poor response after 24–48 hours, and 5) good nursing care including cautious handling of both
the ill and exposed cattle. In those cattle where over 50% of the lung tissue has been damaged
prior to initiation of effective treatment, there will be a poor response, many relapses, and a high
mortality rate.
Group (or mass) treatment may be of value in some situations and aid in reducing the
number of cattle severely affected with BRD. It can also delay use of more effective, individual
treatment and result in a greater loss. It is preferable to include the antibiotic or sulfa in the
drinking water rather than the feed since the ill cattle quickly go off feed but usually continue to
drink water a little longer.
PREVENTION OF BRD
The two major areas to emphasize for prevention are management and vaccination. Of the
two, management is usually much more important.
1. Management
Evaluate all the possible causes for stress on the cattle and determine which ones can
reasonably be eliminated or at least reduced. Look carefully at alternative methods of operation
and at specific timing of processing, vaccinating, etc. Recognize the critical period for disease
detection during the three weeks immediately following weaning, placing on feed, or shipping of
cattle. Avoid mixing (co-mingling) cattle from different sources during this highly critical three
week period. Preconditioning does reduce the rate of illness and death but must be evaluated in
terms of economic costs and benefits for the specific producer involved. Arrange the pens and
feeders to keep new cattle close to the feed and water supplies. Don’t overcrowd, especially early
in the feeding period. Control the dust and mud. 
2. Vaccines
Vaccines are available for several infectious diseases of cattle. However, with the various
brand names as well as different combinations available, the choice of vaccines can become very
complicated. The six respiratory disease agents for which vaccines are available are categorized
and briefly described below. 
Calves vaccinated under 6 months of age should generally be re-vaccinated after that age
to provide a longer lasting immunity. It is important to follow the specific directions provided
with a vaccine. If two doses are recommended initially, don’t count on very much protection until
7–14 days after the second dose has been given. 
A) IBR (Infectious Bovine Rhinotracheitis—Rednose): A viral infection of the upper
respiratory tract. It is present in almost all herds, but causes illness in unexposed animals or those
with lowered levels of immunity. Many cattle carry the virus and begin shedding it to others
during times of stress. This agent is commonly implicated with bacterial agents in causing shipping
fever and other severe cases of pneumonia. 
Both MLV (modified live virus) vaccines and killed (or attenuated) products are available.
Some are designed for IM (intramuscular) use while others are given IN (intranasally). The
killed and intranasal products may be used for, or around, pregnant cows but some other vaccines
may cause abortions. The IN vaccines will cause some antibody response within 3 days and may
be useful even in the face of an outbreak. Two doses of a killed product must be used to confer
protective immunity. 
B) PI3 (Parainfluenza-3): Another viral respiratory agent that causes a relatively mild
disease by itself, but a severe problem when combined with a bacterial agent. It is often included
with IBR vaccines and can be used on the same schedule. 
C) BVD (Bovine Virus Diarrhea): A common viral agent, present in almost all herds. It
may cause respiratory, digestive tract or reproductive problems. It has a profound detrimental
affect on the immune system. 
A number of MLV vaccines have been available for BVD. Killed vaccines are now
available which stimulate good immunity, but two doses of these are required initially. 
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D) BRSV (Bovine Respiratory Syncytial Virus): A relatively recently recognized
disease agent, but now identified all across the country in respiratory infections. It is mainly a
problem in weaner and feedlot animals (also young dairy stock). Killed virus vaccines are available
with two initial doses required. Modified live virus vaccines are also available.
E) Pasteurella: A bacteria carried by many normal cattle. It becomes a major cause of
severe “shipping fever” pneumonia when combined with stress and a viral agent. Two species are
common: P. hemolytica and P. multocida. Vaccines available in the past were poor, and use of a
single dose caused more problems than if none were used. 
Great improvements have been made in recent years and several products are available,
with more to come. Some of the killed products require two doses to stimulate protective
immunity, but others are available for which one dose is sufficient. Attenuated (modified live)
vaccines are also available. Follow directions carefully for these products to be beneficial. They
must usually be given prior to weaning in order to help hold down the occurrence of disease at
this critical time. 
F) Haemophilus somnus: This agent is the other major bacterial agent involved in
shipping fever. It also causes “brain fever” in feedlot cattle (also known as TEME:
thromboembolic meningioencephalitis). The killed vaccine must be given in two doses initially and
should be used prior to weaning for the greatest benefit.
